相似文献
1
NNMT: A Bad Actor in Fat Makes Good in Liver.
Cell Metab. 2015 Aug 4;22(2):200-1. doi: 10.1016/j.cmet.2015.07.017.
2
Nicotinamide N-methyltransferase regulates hepatic nutrient metabolism through Sirt1 protein stabilization.
Nat Med. 2015 Aug;21(8):887-94. doi: 10.1038/nm.3882. Epub 2015 Jul 13.
3
Body weight predicts Nicotinamide N-Methyltransferase activity in mouse fat.
Endocr Res. 2018 Feb;43(1):55-63. doi: 10.1080/07435800.2017.1381972. Epub 2017 Oct 16.
4
Inhibiting proliferation in KB cancer cells by RNA interference-mediated knockdown of nicotinamide N-methyltransferase expression.
Int J Immunopathol Pharmacol. 2011 Jan-Mar;24(1):69-77. doi: 10.1177/039463201102400109.
5
Tissue-specific regulation of sirtuin and nicotinamide adenine dinucleotide biosynthetic pathways identified in C57Bl/6 mice in response to high-fat feeding.
J Nutr Biochem. 2016 Nov;37:20-29. doi: 10.1016/j.jnutbio.2016.07.013. Epub 2016 Aug 14.
6
Nicotinamide N-methyltransferase induces cellular invasion through activating matrix metalloproteinase-2 expression in clear cell renal cell carcinoma cells.
Carcinogenesis. 2011 Feb;32(2):138-45. doi: 10.1093/carcin/bgq225. Epub 2010 Nov 2.
7
Human liver nicotinamide N-methyltransferase: ion-pairing radiochemical assay, biochemical properties and individual variation.
Clin Chim Acta. 1990 Jan 31;186(3):359-74. doi: 10.1016/0009-8981(90)90322-j.
8
Nicotinamide N-methyltransferase increases complex I activity in SH-SY5Y cells via sirtuin 3.
Biochem Biophys Res Commun. 2015 Nov 20;467(3):491-6. doi: 10.1016/j.bbrc.2015.10.023. Epub 2015 Oct 8.
9
Nicotinamide N-Methyltransferase: More Than a Vitamin B3 Clearance Enzyme.
Trends Endocrinol Metab. 2017 May;28(5):340-353. doi: 10.1016/j.tem.2017.02.004. Epub 2017 Mar 11.
10
HPLC-UV method for measuring nicotinamide N-methyltransferase activity in biological samples: evidence for substrate inhibition kinetics.
J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Mar 15;921-922:87-95. doi: 10.1016/j.jchromb.2013.01.030. Epub 2013 Feb 4.
引用本文的文献
1
Nicotinamide N-methyltransferase inhibition mitigates obesity-related metabolic dysfunction.
Diabetes Obes Metab. 2024 Nov;26(11):5272-5282. doi: 10.1111/dom.15879. Epub 2024 Aug 19.
2
Nicotinamide N-Methyltransferase (NNMT): A New Hope for Treating Aging and Age-Related Conditions.
Metabolites. 2024 Jun 19;14(6):343. doi: 10.3390/metabo14060343.
3
Nicotinamide N-methyltransferase (NNMT): a novel therapeutic target for metabolic syndrome.
Front Pharmacol. 2024 Jun 11;15:1410479. doi: 10.3389/fphar.2024.1410479. eCollection 2024.
4
Molecular Mechanisms of IL18 in Disease.
Int J Mol Sci. 2023 Dec 6;24(24):17170. doi: 10.3390/ijms242417170.
5
Elucidating the role of nicotinamide N-methyltransferase-p53 axis in the progression of chronic kidney disease.
PeerJ. 2023 Nov 8;11:e16301. doi: 10.7717/peerj.16301. eCollection 2023.
6
Nicotinamide N-methyltransferase and liver diseases.
Genes Dis. 2022 Apr 20;10(5):1883-1893. doi: 10.1016/j.gendis.2022.03.019. eCollection 2023 Sep.
7
The Storage Conditions of High-Fat Diet Are the Key Factors for Diet-Induced Obesity and Liver Damage.
Nutrients. 2022 May 26;14(11):2222. doi: 10.3390/nu14112222.
8
NAD Precursors Repair Mitochondrial Function in Diabetes and Prevent Experimental Diabetic Neuropathy.
Int J Mol Sci. 2022 Apr 28;23(9):4887. doi: 10.3390/ijms23094887.
9
Nicotinamide -Methyltransferase in Health and Cancer.
Int J Tryptophan Res. 2017 Jun 30;10:1178646917691739. doi: 10.1177/1178646917691739. eCollection 2017.
10
Roles of Nicotinamide N-Methyltransferase in Obesity and Type 2 Diabetes.
Biomed Res Int. 2021 Jul 27;2021:9924314. doi: 10.1155/2021/9924314. eCollection 2021.
本文引用的文献
1
Nicotinamide N-methyltransferase regulates hepatic nutrient metabolism through Sirt1 protein stabilization.
Nat Med. 2015 Aug;21(8):887-94. doi: 10.1038/nm.3882. Epub 2015 Jul 13.
2
Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity.
Nature. 2014 Apr 10;508(7495):258-62. doi: 10.1038/nature13198.
3
Targeted, LCMS-based Metabolomics for Quantitative Measurement of NAD(+) Metabolites.
Comput Struct Biotechnol J. 2013 May 27;4:e201301012. doi: 10.5936/csbj.201301012. eCollection 2013.
4
SIRT1 and other sirtuins in metabolism.
Trends Endocrinol Metab. 2014 Mar;25(3):138-45. doi: 10.1016/j.tem.2013.12.001. Epub 2013 Dec 30.
5
Mitochondrial protein acetylation as a cell-intrinsic, evolutionary driver of fat storage: chemical and metabolic logic of acetyl-lysine modifications.
Crit Rev Biochem Mol Biol. 2013 Nov-Dec;48(6):561-74. doi: 10.3109/10409238.2013.838204. Epub 2013 Sep 19.
6
High-fat diet triggers inflammation-induced cleavage of SIRT1 in adipose tissue to promote metabolic dysfunction.
Cell Metab. 2012 Aug 8;16(2):180-8. doi: 10.1016/j.cmet.2012.07.003.
7
Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition.
Annu Rev Nutr. 2008;28:115-30. doi: 10.1146/annurev.nutr.28.061807.155443.
8
NAD+ metabolism in health and disease.
Trends Biochem Sci. 2007 Jan;32(1):12-9. doi: 10.1016/j.tibs.2006.11.006. Epub 2006 Dec 11.
9
Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1.
Nature. 2005 Mar 3;434(7029):113-8. doi: 10.1038/nature03354.
Zotero 插件